Herpes Labialis (Oral Herpes) Drugs Market Report

Global and Region Herpes Labialis (Oral Herpes) Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：207
  • REPORT CODE：GMM925339
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Herpes Labialis (Oral Herpes) Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Herpes Labialis (Oral Herpes) Drugsmarket, defines the market attractiveness level of Herpes Labialis (Oral Herpes) Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Herpes Labialis (Oral Herpes) Drugs industry, describes the types of Herpes Labialis (Oral Herpes) Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Herpes Labialis (Oral Herpes) Drugs market and the development prospects and opportunities of Herpes Labialis (Oral Herpes) Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Herpes Labialis (Oral Herpes) Drugs market in Chapter 13.

    By Player:

    • Haiwang

    • Luoxin

    • Teva

    • Med shine

    • HETERO

    • Cadila

    • Livzon

    • Mylan

    • Roxane

    • GSK

    • Beech Tree

    • Kelun Group

    • Onxeo

    • Apotex

    • Foamix

    • Novartis

    By Type:

    • External Use

    • Oral

    • Injection

    By End-User:

    • Valacyclovir

    • Aciclovir

    • Famciclovir

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Herpes Labialis (Oral Herpes) Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Herpes Labialis (Oral Herpes) Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Herpes Labialis (Oral Herpes) Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Herpes Labialis (Oral Herpes) Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Herpes Labialis (Oral Herpes) Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Herpes Labialis (Oral Herpes) Drugs Consumption (2017-2022)

    • 7.2 United States Herpes Labialis (Oral Herpes) Drugs Consumption (2017-2022)

    • 7.3 Europe Herpes Labialis (Oral Herpes) Drugs Consumption (2017-2022)

    • 7.4 China Herpes Labialis (Oral Herpes) Drugs Consumption (2017-2022)

    • 7.5 Japan Herpes Labialis (Oral Herpes) Drugs Consumption (2017-2022)

    • 7.6 India Herpes Labialis (Oral Herpes) Drugs Consumption (2017-2022)

    • 7.7 South Korea Herpes Labialis (Oral Herpes) Drugs Consumption (2017-2022)

    8 Region and Country-wise Herpes Labialis (Oral Herpes) Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Herpes Labialis (Oral Herpes) Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Herpes Labialis (Oral Herpes) Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Herpes Labialis (Oral Herpes) Drugs Consumption Forecast (2022-2028)

    • 8.4 China Herpes Labialis (Oral Herpes) Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Herpes Labialis (Oral Herpes) Drugs Consumption Forecast (2022-2028)

    • 8.6 India Herpes Labialis (Oral Herpes) Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Herpes Labialis (Oral Herpes) Drugs Consumption Forecast (2022-2028)

    9 Global Herpes Labialis (Oral Herpes) Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Herpes Labialis (Oral Herpes) Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global External Use Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Oral Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Injection Consumption and Growth Rate (2017-2022)

    • 9.2 Global Herpes Labialis (Oral Herpes) Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Valacyclovir Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Aciclovir Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Famciclovir Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Herpes Labialis (Oral Herpes) Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Herpes Labialis (Oral Herpes) Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global External Use Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Oral Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Injection Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Herpes Labialis (Oral Herpes) Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Valacyclovir Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Aciclovir Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Famciclovir Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Herpes Labialis (Oral Herpes) Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Herpes Labialis (Oral Herpes) Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Herpes Labialis (Oral Herpes) Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Herpes Labialis (Oral Herpes) Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Herpes Labialis (Oral Herpes) Drugs Market Competitive Analysis

    • 14.1 Haiwang

      • 14.1.1 Haiwang Company Details

      • 14.1.2 Haiwang Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Haiwang Herpes Labialis (Oral Herpes) Drugs Product and Service

    • 14.2 Luoxin

      • 14.2.1 Luoxin Company Details

      • 14.2.2 Luoxin Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Luoxin Herpes Labialis (Oral Herpes) Drugs Product and Service

    • 14.3 Teva

      • 14.3.1 Teva Company Details

      • 14.3.2 Teva Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Teva Herpes Labialis (Oral Herpes) Drugs Product and Service

    • 14.4 Med shine

      • 14.4.1 Med shine Company Details

      • 14.4.2 Med shine Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Med shine Herpes Labialis (Oral Herpes) Drugs Product and Service

    • 14.5 HETERO

      • 14.5.1 HETERO Company Details

      • 14.5.2 HETERO Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 HETERO Herpes Labialis (Oral Herpes) Drugs Product and Service

    • 14.6 Cadila

      • 14.6.1 Cadila Company Details

      • 14.6.2 Cadila Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Cadila Herpes Labialis (Oral Herpes) Drugs Product and Service

    • 14.7 Livzon

      • 14.7.1 Livzon Company Details

      • 14.7.2 Livzon Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Livzon Herpes Labialis (Oral Herpes) Drugs Product and Service

    • 14.8 Mylan

      • 14.8.1 Mylan Company Details

      • 14.8.2 Mylan Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Mylan Herpes Labialis (Oral Herpes) Drugs Product and Service

    • 14.9 Roxane

      • 14.9.1 Roxane Company Details

      • 14.9.2 Roxane Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Roxane Herpes Labialis (Oral Herpes) Drugs Product and Service

    • 14.10 GSK

      • 14.10.1 GSK Company Details

      • 14.10.2 GSK Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 GSK Herpes Labialis (Oral Herpes) Drugs Product and Service

    • 14.11 Beech Tree

      • 14.11.1 Beech Tree Company Details

      • 14.11.2 Beech Tree Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Beech Tree Herpes Labialis (Oral Herpes) Drugs Product and Service

    • 14.12 Kelun Group

      • 14.12.1 Kelun Group Company Details

      • 14.12.2 Kelun Group Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Kelun Group Herpes Labialis (Oral Herpes) Drugs Product and Service

    • 14.13 Onxeo

      • 14.13.1 Onxeo Company Details

      • 14.13.2 Onxeo Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Onxeo Herpes Labialis (Oral Herpes) Drugs Product and Service

    • 14.14 Apotex

      • 14.14.1 Apotex Company Details

      • 14.14.2 Apotex Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Apotex Herpes Labialis (Oral Herpes) Drugs Product and Service

    • 14.15 Foamix

      • 14.15.1 Foamix Company Details

      • 14.15.2 Foamix Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Foamix Herpes Labialis (Oral Herpes) Drugs Product and Service

    • 14.16 Novartis

      • 14.16.1 Novartis Company Details

      • 14.16.2 Novartis Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Novartis Herpes Labialis (Oral Herpes) Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Herpes Labialis (Oral Herpes) Drugs

    • Figure Herpes Labialis (Oral Herpes) Drugs Picture

    • Table Global Herpes Labialis (Oral Herpes) Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Herpes Labialis (Oral Herpes) Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Herpes Labialis (Oral Herpes) Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Herpes Labialis (Oral Herpes) Drugs Consumption by Country (2017-2022)

    • Figure United States Herpes Labialis (Oral Herpes) Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Herpes Labialis (Oral Herpes) Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Herpes Labialis (Oral Herpes) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Herpes Labialis (Oral Herpes) Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Herpes Labialis (Oral Herpes) Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Herpes Labialis (Oral Herpes) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Herpes Labialis (Oral Herpes) Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Herpes Labialis (Oral Herpes) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Herpes Labialis (Oral Herpes) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Herpes Labialis (Oral Herpes) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Herpes Labialis (Oral Herpes) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Herpes Labialis (Oral Herpes) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Herpes Labialis (Oral Herpes) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global External Use Consumption and Growth Rate (2017-2022)

    • Figure Global Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Injection Consumption and Growth Rate (2017-2022)

    • Figure Global Valacyclovir Consumption and Growth Rate (2017-2022)

    • Figure Global Aciclovir Consumption and Growth Rate (2017-2022)

    • Figure Global Famciclovir Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global External Use Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Valacyclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Aciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Famciclovir Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Herpes Labialis (Oral Herpes) Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Herpes Labialis (Oral Herpes) Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table Haiwang (Foundation Year, Company Profile and etc.)

    • Table Haiwang Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Haiwang Herpes Labialis (Oral Herpes) Drugs Product and Service

    • Table Luoxin (Foundation Year, Company Profile and etc.)

    • Table Luoxin Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Luoxin Herpes Labialis (Oral Herpes) Drugs Product and Service

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Herpes Labialis (Oral Herpes) Drugs Product and Service

    • Table Med shine (Foundation Year, Company Profile and etc.)

    • Table Med shine Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Med shine Herpes Labialis (Oral Herpes) Drugs Product and Service

    • Table HETERO (Foundation Year, Company Profile and etc.)

    • Table HETERO Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table HETERO Herpes Labialis (Oral Herpes) Drugs Product and Service

    • Table Cadila (Foundation Year, Company Profile and etc.)

    • Table Cadila Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cadila Herpes Labialis (Oral Herpes) Drugs Product and Service

    • Table Livzon (Foundation Year, Company Profile and etc.)

    • Table Livzon Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Livzon Herpes Labialis (Oral Herpes) Drugs Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Herpes Labialis (Oral Herpes) Drugs Product and Service

    • Table Roxane (Foundation Year, Company Profile and etc.)

    • Table Roxane Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roxane Herpes Labialis (Oral Herpes) Drugs Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Herpes Labialis (Oral Herpes) Drugs Product and Service

    • Table Beech Tree (Foundation Year, Company Profile and etc.)

    • Table Beech Tree Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beech Tree Herpes Labialis (Oral Herpes) Drugs Product and Service

    • Table Kelun Group (Foundation Year, Company Profile and etc.)

    • Table Kelun Group Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kelun Group Herpes Labialis (Oral Herpes) Drugs Product and Service

    • Table Onxeo (Foundation Year, Company Profile and etc.)

    • Table Onxeo Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Onxeo Herpes Labialis (Oral Herpes) Drugs Product and Service

    • Table Apotex (Foundation Year, Company Profile and etc.)

    • Table Apotex Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apotex Herpes Labialis (Oral Herpes) Drugs Product and Service

    • Table Foamix (Foundation Year, Company Profile and etc.)

    • Table Foamix Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Foamix Herpes Labialis (Oral Herpes) Drugs Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Herpes Labialis (Oral Herpes) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Herpes Labialis (Oral Herpes) Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US